Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Alopecia areata is hard to treat, but new targeted therapies show promise.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The document concludes that hair follicle regeneration involves various factors like stem cells, noncoding dsRNA, lymphatic vessels, growth factors, minoxidil, exosomes, and induced pluripotent stem cells.

Other common signs, not just the well-known immune cells around hair bulbs, are important for diagnosing hair loss from alopecia areata.

Eosinophilic infiltrate is not a reliable indicator for diagnosing chronic alopecia areata.

Finding eosinophils near hair bulbs helps diagnose alopecia areata.

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

Different types of hair loss have unique features under a microscope, but a doctor's exam is important for accurate diagnosis.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

Psoriasis or contact dermatitis can override alopecia areata, allowing hair growth.

Lymphocytes may hinder hair stem cells, causing hair loss without scarring.

A hand-held dermatoscope helped differentiate between pressure-induced alopecia and alopecia areata in a young patient, who then experienced hair regrowth within a month.

The study found that the cause of alopecia areata can be identified through tissue analysis, and vertical sections are enough for diagnosis.

A rare form of alopecia causes hair thinning without bald spots and may be more common than thought, responding well to steroid treatment.

Two siblings both had a rare case of alopecia areata at the same time.

A woman had temporary hair loss after a facelift, which improved on its own within a year.

Scalp biopsies help tell apart androgenetic alopecia and alopecia areata.

Trichoscopy helped diagnose and treat a woman with two different types of hair loss.

Hair loss in both Androgenetic Alopecia and Alopecia Areata is often accompanied by inflammation around hair follicles, but the location and severity of this inflammation varies.

A combination of ciclosporin and ketoconazole can effectively treat severe hair loss in dogs.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Alopecia areata causes patchy hair loss and is often treated with corticosteroids.

Histopathological examination is essential for diagnosing alopecia areata.